Skip to content

Multi-Nutrient Supplement for Radio-Protection

Multi-Nutrient Supplement for Radio-Protection

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04781868
Acronym
MNSRP
Enrollment
30
Registered
2021-03-04
Start date
2024-07-01
Completion date
2025-07-01
Last updated
2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DNA Damage, Radiation Induced, Oxidative Stress, Radiation Exposure

Brief summary

Exposure to radiation, such as during routine CTs, bone scans, or X-rays, causes oxidative stress which can damage the DNA (your genetic material) within your white blood cells. While the amount of DNA damage that may occur from one scan is not harmful to your overall health, there could be concerning damage in patients who are constantly exposed to this radiation. Currently, there is no way to prevent DNA damage during a medical scan. One potential way to fight the oxidative stress caused by radiation is to take an antioxidant before a scan. The purpose of this study is to see if a combination of antioxidants can protect someone from the damage that radiation causes to the DNA of their white blood cells.

Interventions

Multi-nutrient supplement containing a combination of vitamins, minerals and antioxidants

DRUGPlacebo

Placebo

Sponsors

McMaster University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 to 76 years. * Scheduled for bone scan procedure at the Juravinski Hospital.

Exclusion criteria

* History of smoking within six months prior to study enrollment. * Known hypersensitivity reactions to any of the ingredients in the MNSRP. * Chemotherapy or radiation therapy within six months prior or one month following study enrollment. * Individuals currently taking vitamin or mineral supplements that contain antioxidants will be considered on a case-by-case basis but will be asked to refrain from intake for at least two weeks prior to partaking in this study.

Design outcomes

Primary

MeasureTime frameDescription
Number of gamma-H2Ax foci per PBMC nucleusThree hours following radiation exposureNumber of gamma-H2Ax foci per PBMC nucleus three hours following radiation exposure

Secondary

MeasureTime frameDescription
Amount of amplifiable mtDNA in PBMC'sThree hours following radiation exposureAmount of amplifiable mtDNA in PBMC's three hours following radiation exposure
Abundance of mtDNA deletions in PBMC'sThree hours following radiation exposureAbundance of mtDNA deletions in PBMC's three hours following radiation exposure
Abundance of phosphorus-ATM in PBMC'sThree hours following radiation exposureAbundance of phosphorus-ATM in PMBC's three hours following radiation exposure

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026